Boosters Effectively Fend Off Delta, Omicron Variants in Studies

Booster doses of Covid-19 vaccines increased protection against both the delta and omicron variants in three studies that looked at infections, hospital admissions and deaths in thousands of U.S. patients. Third doses of messenger RNA vaccines made by Moderna Inc. and the partnership of Pfizer Inc. and BioNTech SE were at least 90% effective in preventing hospitalizations during both the delta and omicron periods, according to an analysis of hundreds of thousands of hospitalizations and clinic visits. The shots’ protection against Covid deaths was diminished after omicron’s rise, but remained significant, according to a separate study from the U.S. Centers for Disease Control and Prevention. Subscribe to our YouTube channel: https://bit.ly/2TwO8Gm Subscribe to our newest channel Quicktake Explained: https://bit.ly/3iERrup Bloomberg Quicktake brings you live global news and original shows spanning business, technology, politics and culture. Make sense of the stories changing your business and your world. To watch complete coverage on Bloomberg Quicktake 24/7, visit http://www.bloomberg.com/qt/live, or watch on Apple TV, Roku, Samsung Smart TV, Fire TV and Android TV on the Bloomberg app. Have a story to tell? Fill out this survey for a chance to have it featured on Bloomberg Quicktake: https://cor.us/surveys/27AF30 Connect with us on… YouTube:    / bloomberg   Breaking News on YouTube:    / bloombergquicktakenews   Twitter:   / quicktake   Facebook:   / quicktake   Instagram:   / quicktake